Request Trial
official_portrait_of_michelle_donelan_mp
(Photo source UK Parliament website. Used under Creative Commons).
7 September 2023FeaturesPharmaSarah Speight

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

Today, the British scientific community woke to the news that the UK has finally rejoined Horizon Europe, the European Union’s €95.5 billion ($102 billion) research funding programme.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Pharma
Beyond the primary patent: How pharma can build competitive barriers
16 September 2026   A medicine reaching the end of its primary patent term does not necessarily mean the market is open to generics. The complex patent landscape surrounding semaglutide shows how secondary patents covering indications, formulations and manufacturing processes can extend competitive barriers—and why careful freedom-to-operate analysis is critical before launch, says Ana Neves of Inventa.
Pharma
J&J unit win shuts door on Sandoz generic launch
10 September 2026   Four patents stood firm in a Johnson & Johnson unit’s fight with Sandoz, leaving the generics maker facing a lengthy wait before its esketamine nasal spray can reach the US market.
Pharma
Italy’s Biofer falls short in Fed Circ appeal over key claim wording
7 September 2026   A single phrase in a patent has proved decisive in Biofer’s infringement fight with Vifor, with the Federal Circuit exposing the risks of small claim-drafting choices for life sciences companies.


Editor's picks

Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients
Regulation & Industry
Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients
14 September 2026

Editor's picks

Regulation & Industry
Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients
14 September 2026
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026

More features

Beyond the primary patent: How pharma can build competitive barriers
Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients
Patent lawyers and judges discuss lofty UPC issues in grand London venue
J&J unit win shuts door on Sandoz generic launch
UK firm hires head of IP with commercial and technical nous
Italy’s Biofer falls short in Fed Circ appeal over key claim wording
10x Genomics wins latest round in Parse patent dispute
Top law firms and individuals recognised in WIPR’s UK Patent Rankings 2026